Differences in Access to Liver Transplantation: Disease Severity, Waiting Time, and Transplantation Center Volume

With population growth and aging, the emergence of new diseases and immunodeficiency, the demand for emergency departments (EDs) increases, making overcrowding in these departments a global problem. Due to the disease severity and transmission rate of COVID-19, it is necessary to provide an accurate and automated triage system to classify and isolate the suspected cases. Different triage methods for COVID-19 patients have been proposed as disease symptoms vary by country. Still, several problems with triage systems remain unresolved, most notably overcrowding in EDs, lengthy waiting times and difficulty adjusting static triage systems when the nature and symptoms of a disease changes. In this paper, we conduct a comprehensive review of general ED triage systems as well as COVID-19 triage systems. We identified important parameters that we recommend considering when designing an e-Triage (electronic triage) system for EDs, namely waiting time, simplicity, reliability, validity, scalability, and adaptability. Moreover, the study proposes a scoring-based e-Triage system for COVID-19 along with several recommended solutions to enhance the overall outcome of e-Triage systems during the outbreak. The recommended solutions aim to reduce overcrowding and overheads in EDs by remotely assessing patients’ conditions and identifying their severity levels.

Download Full-text

Transarterial Chemoembolization for Hepatocellular Carcinoma: Volumetric and Morphologic CT Criteria for Assessment of Prognosis and Therapeutic Success—Results from a Liver Transplantation Center

Radiology ◽

10.1148/radiology.214.2.r00fe06349 ◽

2000 ◽

Vol 214 (2) ◽

pp. 349-357 ◽

Cited By ~ 121

Author(s):

Thomas J. Vogl ◽

Michael Trapp ◽

Henrik Schroeder ◽

Martin Mack ◽

Adrian Schuster ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Liver Transplantation ◽

Transarterial Chemoembolization ◽

Therapeutic Success ◽

Transplantation Center

Download Full-text

Five-Year Experience of Liver Transplant at Kerman University of Medical Sciences: Afzalipoor Hospital

Journal of Shahid Sadoughi University of Medical Sciences ◽

10.18502/ssu.v28i10.4920 ◽

2020 ◽

Author(s):

Masood Dehghani

Keyword(s):

Liver Transplantation ◽

Liver Transplant ◽

Cross Sectional Study ◽

Outcome Data ◽

Time Interval ◽

Cross Sectional ◽

The Past ◽

Transplantation Center ◽

Set Up ◽

End Stage

Introduction: The only option for treatment of end stage liver diseases is liver transplantation. Afzalipour Hospital in Kerman, Iran is the third largest liver transplantation center in Iran. In this study, the outcomes of this center have been studied during the past 5 years. Methods: In this cross-sectional study, the pre and post transplantation’s clinical, demographic and outcome data of all patients who received liver transplant at Afzalipour Hospital during the past 5 years have been collected and reviewed. SPSS software ver. 16 was used to analyze the data. Results: Forty-three patients have received liver transplantation during this time interval. The 3-year survival rate of patients was 77%. The most common cause of death was primary nonfunction graft after transplantation. The most common complication was acute rejection (15%), all of which were successfully treated with corticosteroids. Conclusion: Due to increment of cases of acute and chronic liver failure in the community and since the final treatment of these cases is liver transplantation, so there is need to develop liver transplant centers in the future. Quantitative and qualitative study of the activity of centers based liver transplant in Iran is necessary to set up successful centers.

Download Full-text

Pharmaceutical support in liver transplantation at a reference center in Rio Grande do Sul

Brazilian Journal of Transplantation ◽

10.53855/bjt.v20i2.80 ◽

2017 ◽

Vol 20 (2) ◽

pp. 6-8

Author(s):

Mariana de Andrade Pranke ◽

Maria Lúcia Zanotelli ◽

Alfeu Fleck Jr. ◽

Ajácio Brandão ◽

Cláudio Marroni ◽

...

Keyword(s):

Liver Transplantation ◽

Dose Adjustment ◽

Rio Grande ◽

New Drugs ◽

Rio Grande Do Sul ◽

Treatment Results ◽

Reference Center ◽

Transplant Patients ◽

Transplantation Center

The introduction of the everolimus as immunosuppressant in the liver transplantation has been shown to be safe and effective in the prophylaxis and preservation of the renal function. Prospective follow-up and chart analysis of liver transplant patients treated with everolimus was performed. Purpose: To highlight the importance of the pharmacist in transplantation centers. Method: Along the study, 93 patients were included, being 72 under active treatment. The successful treatment depends on the multidisciplinary follow-up, and it is extremely important the involvement of the patient, making him to become positive and an active part of the treatment. Results: The most frequent problems were: patients cutting the everolimus tablet, late SL after dose adjustment, lack of adhesion to the collection, and serum level collection out of time. Discussion: Upon the introduction of new drugs, it is required to observe possible adverse events further to ensure that the patient correctly follows the treatment. Conclusion: The presence of the pharmacist in the transplantation center allows the patient to get a reference to clarify doubts on the proper use of immunosuppressant.

Download Full-text